Severe B cell–mediated disease activation despite two cycles of alemtuzumab in a patient with multiple...

Severe B cell–mediated disease activation despite two cycles of alemtuzumab in a patient with multiple..., Multiple Sclerosis Journal, Ahead of Print. , Multiple Sclerosis Journal, Ahead of Print.
, admin,

No comments: